These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30396939)

  • 21. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
    Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
    Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
    Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
    Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells.
    Oblad R; Doughty H; Lawson J; Christensen M; Kenealey J
    Mol Pharmacol; 2018 Aug; 94(2):907-916. PubMed ID: 29884690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic Effects of the Therapeutic Radionuclide Rhenium-188 Combined with Taxanes in Human Prostate Carcinoma Cell Lines.
    Lange R; ter Heine R; van Wieringen WN; Tromp AM; Paap M; Bloemendal HJ; de Klerk JM; Hendrikse NH; Geldof AA
    Cancer Biother Radiopharm; 2017 Feb; 32(1):16-23. PubMed ID: 28118029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro.
    Oprea-Lager DE; Bijnsdorp IV; VAN Moorselaar RJ; VAN DEN Eertwegh AJ; Hoekstra OS; Geldof AA
    Anticancer Res; 2013 Feb; 33(2):387-91. PubMed ID: 23393328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hesperetin, a citrus flavonoid, attenuates testicular damage in diabetic rats via inhibition of oxidative stress, inflammation, and apoptosis.
    Samie A; Sedaghat R; Baluchnejadmojarad T; Roghani M
    Life Sci; 2018 Oct; 210():132-139. PubMed ID: 30179627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
    Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
    Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
    Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
    Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cells.
    Haddad AQ; Fleshner N; Nelson C; Saour B; Musquera M; Venkateswaran V; Klotz L
    Nutr Cancer; 2010; 62(5):668-81. PubMed ID: 20574928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
    de Bono JS; Oudard S; Ozguroglu M; Hansen S; Machiels JP; Kocak I; Gravis G; Bodrogi I; Mackenzie MJ; Shen L; Roessner M; Gupta S; Sartor AO;
    Lancet; 2010 Oct; 376(9747):1147-54. PubMed ID: 20888992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.
    Zelivianski S; Spellman M; Kellerman M; Kakitelashvilli V; Zhou XW; Lugo E; Lee MS; Taylor R; Davis TL; Hauke R; Lin MF
    Int J Cancer; 2003 Nov; 107(3):478-85. PubMed ID: 14506750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.
    Wang P; Henning SM; Heber D; Vadgama JV
    J Nutr Biochem; 2015 Apr; 26(4):408-15. PubMed ID: 25655047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.
    Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
    J BUON; 2009; 14(3):479-85. PubMed ID: 19810142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
    Kato T; Mizutani K; Kameyama K; Kawakami K; Fujita Y; Nakane K; Kanimoto Y; Ehara H; Ito H; Seishima M; Deguchi T; Ito M
    Urol Oncol; 2015 Sep; 33(9):385.e15-20. PubMed ID: 26027763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
    Ping SY; Hour TC; Lin SR; Yu DS
    Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers.
    Brand W; van der Wel PA; Rein MJ; Barron D; Williamson G; van Bladeren PJ; Rietjens IM
    Drug Metab Dispos; 2008 Sep; 36(9):1794-802. PubMed ID: 18515333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan-based nano-formulation enhances the anticancer efficacy of hesperetin.
    Mary Lazer L; Sadhasivam B; Palaniyandi K; Muthuswamy T; Ramachandran I; Balakrishnan A; Pathak S; Narayan S; Ramalingam S
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1988-1998. PubMed ID: 29032208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?
    Mita AC; Figlin R; Mita MM
    Clin Cancer Res; 2012 Dec; 18(24):6574-9. PubMed ID: 23091116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.